Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | histone acetyltransferase MYST2 | 0.0123251 | 0.106788 | 0.19011 |
Schistosoma mansoni | metabotropic glutamate receptor | 0.00343051 | 0.00628256 | 0.00574261 |
Echinococcus granulosus | chromobox protein 2 | 0.0187575 | 0.179472 | 0.320166 |
Echinococcus multilocularis | metabotropic glutamate receptor 5 | 0.00504152 | 0.0244864 | 0.042843 |
Echinococcus multilocularis | polycomb protein SCMH1 | 0.0290821 | 0.296137 | 0.52892 |
Schistosoma mansoni | phd finger protein | 0.00435833 | 0.0167666 | 0.0162323 |
Brugia malayi | C2-HC type zinc finger protein C.e-MyT1 | 0.0123251 | 0.106788 | 0.183802 |
Echinococcus multilocularis | tumor suppressor p53 binding protein 1 | 0.0413981 | 0.435304 | 0.777938 |
Schistosoma mansoni | myelin transcription factor 1 myt1 | 0.0123251 | 0.106788 | 0.106303 |
Brugia malayi | mbt repeat family protein | 0.0313008 | 0.321207 | 0.554741 |
Plasmodium falciparum | JmjC domain-containing protein, putative | 0.00287452 | 0 | 0.5 |
Echinococcus multilocularis | metabotropic glutamate receptor 2 | 0.00343051 | 0.00628256 | 0.0102699 |
Echinococcus granulosus | Jumonji AT rich interactive domain 1B | 0.0117883 | 0.100723 | 0.179256 |
Schistosoma mansoni | sex comb on midleg homolog | 0.0290821 | 0.296137 | 0.295755 |
Echinococcus granulosus | SAM and MBT domain containing protein | 0.0450066 | 0.476078 | 0.850897 |
Echinococcus multilocularis | suppression of tumorigenicity 18 protein | 0.0123251 | 0.106788 | 0.19011 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.00958295 | 0.075803 | 0.0753008 |
Brugia malayi | metabotropic glutamate receptor subtype 5a (mGluR5a), putative | 0.00371014 | 0.00944223 | 0.0153953 |
Echinococcus multilocularis | Jumonji, AT rich interactive domain 1B | 0.0117883 | 0.100723 | 0.179256 |
Schistosoma mansoni | hypothetical protein | 0.0413981 | 0.435304 | 0.434997 |
Brugia malayi | mbt repeat family protein | 0.0540783 | 0.578586 | 1 |
Schistosoma mansoni | scm-relatedprotein containing 4 mbt domains (sfmbt) | 0.0450066 | 0.476078 | 0.475794 |
Echinococcus granulosus | endonuclease exonuclease phosphatase | 0.0523809 | 0.559406 | 1 |
Onchocerca volvulus | Polycomb protein Sfmbt homolog | 0.0540783 | 0.578586 | 1 |
Echinococcus granulosus | polycomb protein SCMH1 | 0.0290821 | 0.296137 | 0.52892 |
Schistosoma mansoni | metabotropic glutamate receptor 2 3 (mglur group 2) | 0.00465646 | 0.0201354 | 0.019603 |
Echinococcus multilocularis | histone acetyltransferase MYST2 | 0.0123251 | 0.106788 | 0.19011 |
Echinococcus multilocularis | SAM and MBT domain containing protein | 0.0450066 | 0.476078 | 0.850897 |
Schistosoma mansoni | sex comb on midleg homolog | 0.0290821 | 0.296137 | 0.295755 |
Loa Loa (eye worm) | mbt repeat family protein | 0.0313008 | 0.321207 | 0.554741 |
Echinococcus granulosus | metabotropic glutamate receptor 2 | 0.00343051 | 0.00628256 | 0.0102699 |
Echinococcus granulosus | tumor suppressor p53 binding protein 1 | 0.0413981 | 0.435304 | 0.777938 |
Brugia malayi | Metabotropic glutamate receptor precursor. | 0.00409519 | 0.0137932 | 0.0229225 |
Brugia malayi | jmjC domain containing protein | 0.0139869 | 0.125566 | 0.216286 |
Echinococcus multilocularis | lysine specific demethylase 5A | 0.00764007 | 0.0538492 | 0.0953832 |
Echinococcus multilocularis | chromobox protein 2 | 0.0187575 | 0.179472 | 0.320166 |
Loa Loa (eye worm) | glutamate receptor | 0.00409519 | 0.0137932 | 0.0229225 |
Echinococcus multilocularis | endonuclease exonuclease phosphatase | 0.0523809 | 0.559406 | 1 |
Echinococcus granulosus | lysine specific demethylase 5A | 0.00958295 | 0.075803 | 0.134666 |
Echinococcus granulosus | histone acetyltransferase myst3 | 0.00435833 | 0.0167666 | 0.0290295 |
Plasmodium vivax | JmjC domain containing protein | 0.00287452 | 0 | 0.5 |
Echinococcus granulosus | suppression of tumorigenicity 18 protein | 0.0123251 | 0.106788 | 0.19011 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.00958295 | 0.075803 | 0.0753008 |
Loa Loa (eye worm) | hypothetical protein | 0.0540783 | 0.578586 | 1 |
Echinococcus granulosus | metabotropic glutamate receptor 5 | 0.00504152 | 0.0244864 | 0.042843 |
Schistosoma mansoni | chromobox protein | 0.0187575 | 0.179472 | 0.179026 |
Echinococcus multilocularis | histone acetyltransferase myst3 | 0.00435833 | 0.0167666 | 0.0290295 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0139869 | 0.125566 | 0.216286 |
Loa Loa (eye worm) | MBCTL1 | 0.0123251 | 0.106788 | 0.183802 |
Toxoplasma gondii | PLU-1 family protein | 0.00440392 | 0.0172818 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0913727 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.00504152 | 0.0244864 | 0.0414215 |
Loa Loa (eye worm) | hypothetical protein | 0.0123251 | 0.106788 | 0.183802 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (ADMET) | Acute toxicity in NMRI mouse infected with GFP-transfected Plasmodium berghei ANKA at 150 mg/kg, ip | ChEMBL. | 23995215 | |
Activity (functional) | Antimalarial activity against GFP-transfected Plasmodium berghei ANKA infected in NMRI mouse assessed as increase of mean survival time at 50 mg/kg, po qd for 4 days | ChEMBL. | 23995215 | |
Activity (functional) | Antimalarial activity against GFP-transfected Plasmodium berghei ANKA infected in NMRI mouse assessed as reduction of parasitaemia at 50 mg/kg, po qd for 4 days | ChEMBL. | 23995215 | |
IC50 (functional) | = 0.015 uM | Antimalarial activity against erythrocytic stage of chloroquine and pyrimethamine-resistant Plasmodium falciparum K1 | ChEMBL. | 23995215 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | 23995215 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.